| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,119 | 0,228 | 29.10. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.10. | LIFETECH SCI ICS Elpis Bioresorbable Peripheral Balloon Expandable Covered Stent System Enters Innovative Medical Device Special Review Procedure | 1 | AASTOCKS | ||
| 20.10. | LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - ADMISSION OF THE ICS ELPIS BIORESORBABLE PERIPHERAL BALLOON-EXPANDABLE COVERED SCAFFOLD SYSTEM INTO SPECIAL ... | 1 | HKEx | ||
| 24.09. | LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - ADMISSION OF THE SURECHAM TM AORTIC ARCH SINGLE-BRANCH STENT GRAFT SYSTEM INTO SPECIAL EXAMINATION AND ... | - | HKEx | ||
| 11.09. | LIFETECH SCI (01302): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 11.09. | LIFETECH SCI (01302): INTERIM REPORT 2026 | - | HKEx | ||
| 11.09. | LIFETECH SCI (01302): NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED SHAREHOLDERS | - | HKEx | ||
| LIFETECH SCIENTIFIC Aktie jetzt für 0€ handeln | |||||
| 10.09. | LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - ADMISSION OF THE LANTVAL TM AORTIC VALVE REPLACEMENT SYSTEM INTO SPECIAL EXAMINATION AND APPROVAL PROCEDURE ... | 2 | HKEx | ||
| 28.08. | LifeTech Scientific Corporation Announces 2026 Interim Results | 455 | PR Newswire | HONG KONG, Aug. 28, 2026 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code:... ► Artikel lesen | |
| 28.08. | LifeTech Scientific Slips To Loss In H1 On Higher Charges, Lower Revenue | 7 | RTTNews | ||
| 28.08. | LIFETECH SCI (01302): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 3 | HKEx | ||
| 12.08. | LIFETECH SCI (01302): PROFIT WARNING | 1 | HKEx | ||
| 12.08. | LIFETECH SCI (01302): APPOINTMENT OF AUTHORISED REPRESENTATIVE | - | HKEx | ||
| 12.08. | LIFETECH SCI (01302): NOTICE OF BOARD MEETING | - | HKEx | ||
| 20.07. | LIFETECH SCI (01302): ANNOUNCEMENT ON NOT TO PROCEED WITH THE MAJOR TRANSACTION | - | HKEx | ||
| 18.06. | LIFETECH SCI (01302): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| 18.06. | LIFETECH SCI (01302): (1) REDESIGNATION OF DIRECTOR; (2) CHANGE OF COMPOSITION OF THE AUDIT COMMITTEE AND THE REMUNERATION COMMITTEE; AND (3) GRANT OF ... | - | HKEx | ||
| 28.05. | LIFETECH SCI (01302): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2026 | - | HKEx | ||
| 22.05. | LIFETECH SCI (01302): MAJOR TRANSACTION - PROPOSED ACQUISITION OF APPROXIMATELY 96.46% EQUITY INTEREST IN STARWAY MEDICAL TECHNOLOGY, INC. * INVOLVING ... | 1 | HKEx | ||
| 22.05. | LIFETECH SCI (01302): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 22.05. | LIFETECH SCI (01302): RESIGNATION OF EXECUTIVE DIRECTORS, AUTHORISED REPRESENTATIVE AND MEMBER OF THE NOMINATION COMMITTEE | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 60,34 | +0,20 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,470 | +2,14 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,890 | +0,70 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,000 | +1,44 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,635 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,020 | -0,50 % | Needham initiates Alignment Healthcare stock rating at Hold | ||
| GERRESHEIMER | 31,900 | -1,24 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| HEARTFLOW | 60,55 | +0,03 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 114,75 | -0,08 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 34,760 | +0,12 % | [Kissigs Nebenwerte-Analyse] Carl Zeiss Meditec: Lässt der Augenspezialist das Tal der Tränen endlich hinter sich? | Im Magazin "Der Nebenwerte Investor" von Traderfox finden sich regelmäßig Analysen von mir zu deutschen Nebenwerten. Das Magazin ist kostenpflichtig und wer dieses oder eine der weiteren Börsenzeitschriften... ► Artikel lesen | |
| GENEDX | 70,98 | -0,06 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CONCENTRA GROUP | 41,250 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,420 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Schedule 14A Preliminary Proxy Statement | ||
| STARLING ONCOLOGY INSTITUTE | 6,650 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| MIMEDX | 3,975 | +0,13 % | Mizuho cuts MiMedx stock price target on wound segment weakness |